Literature DB >> 7127773

Determination of urinary oxalate by reversed-phase ion-pair "high-performance" liquid chromatography.

L Larsson, B Libert, M Asperud.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7127773

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


× No keyword cloud information.
  7 in total

1.  Determination of urinary oxalate by high-performance liquid chromatography monitoring with an ultraviolet detector.

Authors:  K Kataoka; M Takada; Y Kato; M Iguchi; K Kohri; T Kurita
Journal:  Urol Res       Date:  1990

2.  Effects of different doses of alkaline citrate on urine composition and crystallization of calcium oxalate.

Authors:  C Berg; L Larsson; H G Tiselius
Journal:  Urol Res       Date:  1990

3.  Risk factors of calcium stone formation in patients with primary Sjögren's syndrome.

Authors:  P Eriksson; T Denneberg; H G Tiselius
Journal:  Urol Res       Date:  1996

4.  Variability in urinary oxalate measurements between six international laboratories.

Authors:  Naim M Maalouf; Beverley Adams Huet; Andreas Pasch; John C Lieske; John R Asplin; Roswitha Siener; Albrecht Hesse; Jean-Marc Nuoffer; Felix J Frey; John Knight; Ross P Holmes; Joseph E Zerwekh; Olivier Bonny
Journal:  Nephrol Dial Transplant       Date:  2011-03-31       Impact factor: 5.992

5.  Inhibition of calcium oxalate crystallization by urinary macromolecules.

Authors:  H Bek-Jensen; H G Tiselius
Journal:  Urol Res       Date:  1991

6.  Measurement of the risk of calcium oxalate crystallization in urine.

Authors:  H G Tiselius
Journal:  Urol Res       Date:  1985

7.  Evaluation of a high-performance liquid chromatography method for urinary oxalate determination and investigation regarding the pediatric reference interval of spot urinary oxalate to creatinine ratio for screening of primary hyperoxaluria.

Authors:  Ying Shen; Xia Luo; Huijun Li; Qing Guan; Liming Cheng
Journal:  J Clin Lab Anal       Date:  2021-06-07       Impact factor: 2.352

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.